Other

Dataset Information

0

IRE1a silences double stranded RNA through RIDD


ABSTRACT: Chemotherapy is often combined with immune checkpoint inhibitor (ICI) to enhance immunotherapy responses. Despite the approval of chemo-immunotherapy in multiple human cancers including triple-negative breast cancer (TNBC), immunologically cold tumors remain largely unresponsive due to weak chemotherapy-stimulated immune responses. The mechanisms determining the immunogenicity of chemotherapy in immunologically cold tumors remain largely unknown. Here, we identify the endoplasmic reticulum (ER) stress sensor IRE1α as a critical checkpoint that restricts the immunogenicity of taxane chemotherapy and prevents the innate immune recognition of immunologically cold TNBC. IRE1α RNase silences chemotherapy-induced double-stranded RNA (dsRNA) through RIDD (Regulated IRE1-Dependent Decay) to prevent NLRP3 inflammasome–dependent pyroptosis. Inhibition of IRE1α RNase activity with a selective RNase inhibitor ORIN1001, currently in Phase I clinical trial, allows taxane chemotherapy to induce extensive dsRNA accumulation and activate NLRP3 inflammasome–dependent gasdermin D (GSDMD) cleavage. This triggers pyroptosis and a highly effective immune response in immunologically cold TNBC.

ORGANISM(S): Mus musculus

PROVIDER: GSE220315 | GEO | 2024/10/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-04-22 | GSE235695 | GEO
2023-09-18 | GSE217363 | GEO
2024-04-26 | GSE243865 | GEO
2022-07-21 | GSE180524 | GEO
2022-02-21 | PXD023433 | Pride
2024-03-24 | GSE228915 | GEO
2011-05-11 | E-GEOD-25066 | biostudies-arrayexpress
2012-12-01 | E-GEOD-22796 | biostudies-arrayexpress
2022-12-29 | GSE201133 | GEO
2024-07-25 | PXD054126 | Pride